Loading
CT
Crescita Therapeutics Inc. Stock: price and insider trades · Canada
CA·Mcap CA$14.7M
Crescita Therapeutics Inc.: what insiders have been doing
This page follows insider dealings at Crescita Therapeutics Inc. as filed with SEDI. Over the twelve months to 18 October 2026, 32 filings were filed, from 7 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of Crescita Therapeutics Inc. for at least a year. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
32
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,403 of 24,148 companies
50.8
score / 100
Value50
Quality52
FCF yld5.0%
Earn yld-0.6%
EV/EBITDA10.3x
ROE-2.2%
Gross mgn53%
Net mgn-0.4%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.79
Analyst consensus
Income statement
RevenueCA$21.1M
Gross profitCA$11.1M53% margin
EBITDACA$1.5M7% margin
Net income-CA$92k-1.4% margin
Valuation
P/Book1.0x
Beta-0.12
Balance sheet & cash
Market capCA$14.7M
Total debtCA$334k
Free Cash FlowCA$740k
Debt / Equity17%
Profitability & ownership
ROE-2.2%
ROA-3.3%
% insiders24.1%
% institutions3.1%
Last declaration on 9 June 2026
Declarations32 total
120,000 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732286
150,000 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732285
513,000 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732284
997,771 sharesOptionsTSXSEDI:4732283
45,250 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732281
48,000 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732280
228,500 sharesShare Appreciation Rights Plan (SAR)TSXSEDI:4732278
423,000 sharesOptionsTSXSEDI:4732270
142,500 sharesOptionsTSXSEDI:4732268
121,508 shares@ CA$0.80100.0% of flowDeferred Share Units (DSU)TSXSEDI:4732053
59,158 sharesOptionsTSXSEDI:4732052
632,000 shares@ CA$0.8035.4% of flowOptionsTSXSEDI:4732051
95,273 shares@ CA$0.805.3% of flowDeferred Share Units (DSU)TSXSEDI:4732050
95,273 shares@ CA$0.8027.4% of flowDeferred Share Units (DSU)TSXSEDI:4732049
95,273 shares@ CA$0.8062.0% of flowDeferred Share Units (DSU)TSXSEDI:4732048
58,500 shares@ CA$0.8038.0% of flowOptionsTSXSEDI:4732047
59,158 sharesOptionsTSXSEDI:4732046
58,500 shares@ CA$0.8016.8% of flowOptionsTSXSEDI:4732045
32,800 shares@ CA$0.804.4% of flowCommon SharesTSXSEDI:4732044
49,600 shares@ CA$0.806.7% of flowCommon SharesTSXSEDI:4732043
124,879 shares@ CA$0.807.0% of flowCommon SharesTSXSEDI:4732042
11,900 shares@ CA$0.800.7% of flowCommon SharesTSXSEDI:4732041
116,227 shares@ CA$0.806.5% of flowCommon SharesTSXSEDI:4732040
38,795 shares@ CA$0.802.2% of flowCommon SharesTSXSEDI:4732039
119,577 shares@ CA$0.806.7% of flowCommon SharesTSXSEDI:4732038
25 of 32 declarations
About Crescita Therapeutics Inc.
Crescita Therapeutics Inc. is a company focused on the development of pharmaceutical products and skincare solutions. It is listed on the XTSE market.
